Home › Attention Deficit Hyperactivity Disorder › Arkansas
Attention Deficit Hyperactivity Disorder clinical trials in Arkansas
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Arkansas.
Cities in Arkansas
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Little Rock
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Nov 6, 2026 · NCT07717879Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Little Rock
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Nov 6, 2026 · NCT07717892A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Alkermes Investigational Site, Little Rock
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 29, 2026 · NCT07755410Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Preferred Research Partners, Inc., Little Rock
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Oct 5, 2026 · NCT04781140From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.